Warning letterFDA · Mar 6, 2025
Pico IV Inc. MARCS-CMS 700591, March 06, 2025
Named company: Pico IV Inc.
As described below, your “Pico IV” product is an unapproved new drug introduced or delivered for introduction into interstate commerce in violation of sections 505(a) and 301(d) of the Federal Food, Drug,…
Lot information: not specified in this record.